Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Fidelity

Health Care Portfolio Fidelity Advisor Health Care Fund: Class A (FHCLX)

Ticker FHCLX · · Holdings as of May 31, 2026

Expense ratio
0.91%$91/yr per $10k
5-yr return
+4.0%annualized
1-yr return
+14.4%as of Feb 2026
Net assets
$5.8Ball share classes
Holdings
152

Bottom line

Is FHCLX a good fund? The bottom line

FHCLX is the Fidelity Advisor Health Care Fund: Class A share class of Health Care Portfolio, a managed health care sector mutual fund from Fidelity.

Its expense ratio is 0.91% — about $91 a year on every $10,000 invested, cheaper than 54% of health care sector funds we track.

It returned +14.4% over one year, +4.0% a year over five years, +9.0% a year over ten (as of Feb 28, 2026, per its prospectus).

With $5.8 billion in net assets and 152 holdings, its largest position is ELI LILLY and CO (8.0%) and the top 10 make up 38.8% of the portfolio.

What to watch

  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What FHCLX invests in

Health Care Portfolio seeks capital appreciation.

Normally investing at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. These companies may include, for example, companies engaged in the research, development, manufacturing, or marketing of products based on biotechnology research; companies engaged in research, development, or production of pharmaceuticals, including veterinary drugs; manufacturers, distributors, and wholesalers of health care equipment, devices, and supplies including drug delivery systems and eye care products; and owners and operators of health care facilities, HMOs, and other managed plans. For purposes of the fund's policy to normally invest at least 80% of its assets in securities of companies principally engaged in the business activity or activities identified for the fund…

From the fund's prospectus (filed Apr 24, 2026).

FHCLX performance

Fund calendar-year total returns, 2016–2025 2016: −10.7%; 2017: +24.0%; 2018: +7.4%; 2019: +31.5%; 2020: +24.4%; 2021: +11.5%; 2022: −12.8%; 2023: +4.1%; 2024: +4.9%; 2025: +14.4% −11% 2016 +24% 2017 +7% 2018 +31% 2019 +24% 2020 +12% 2021 −13% 2022 +4% 2023 +5% 2024 +14% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
FHCLX+14.4%+4.0%+9.0%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Feb 28, 2026

Full FHCLX performance history →

What FHCLX costs

On a $10,000 investment, FHCLX's 0.91% expense ratio costs about $91 a year. The prospectus estimates $1,630 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full FHCLX fee table →

FHCLX top 10 holdings

#Holding% of fund
1ELI LILLY and CO8.03%
2Danaher Corp6.89%
3JOHNSON and JOHNSON4.91%
4Thermo Fisher Scientific Inc4.33%
5Unitedhealth Group Inc3.49%
6Alnylam Pharmaceuticals Inc2.40%
7Gilead Sciences Inc2.21%
8Boston Scientific Corp2.17%
9Ascendis Pharma A/s2.17%
10Fidelity Revere Street Trust2.17%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 38.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to FHCLX

More funds like FHCLX →

FHCLX FAQ

What is the expense ratio of FHCLX?
FHCLX's expense ratio is 0.91%, which works out to about $91 a year for every $10,000 invested. The prospectus estimates total costs of $1,630 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FHCLX a good investment?
It depends on your goals, but the data points to: 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does FHCLX hold?
FHCLX's largest holdings are ELI LILLY and CO (8.0%), Danaher Corp (6.9%), JOHNSON and JOHNSON (4.9%), Thermo Fisher Scientific Inc (4.3%), Unitedhealth Group Inc (3.5%). It holds 152 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is FHCLX's 5-year return?
FHCLX returned +4.0% a year over the five years ending Feb 28, 2026, and +9.0% a year over ten years. Past performance does not guarantee future results.
Who manages FHCLX?
FHCLX is offered by Fidelity through Fidelity Select Portfolios.